Literature DB >> 2412685

Multicentric giant lymph node hyperplasia. A report of seven cases.

E Kessler.   

Abstract

Multicentric giant lymph node hyperplasia (MGLH) is a distinct lymphoproliferative disorder, which may terminate in malignant lymphoma. The clinical features and laboratory findings of seven cases are reported here. The histologic changes in lymph nodes were those of giant lymph node hyperplasia, plasma cell type. Immunoperoxidase staining showed intracytoplasmatic polyclonal immunoglobulins. Malignant lymphoma supervened in two cases, one of which was proved by autopsy; in the other there was transformation of a polyclonal gammopathy into a monoclonal one. Two of the patients also developed Kaposi's sarcoma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412685     DOI: 10.1002/1097-0142(19851115)56:10<2446::aid-cncr2820561020>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

Review 1.  Portal hypertension and refractory ascites associated with multicentric Castleman's disease.

Authors:  M Abarca; R J Andrade; A García-Arjona; J L Escolar; A Blanes; J M García-Hirschfeld; P González-Santos
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

2.  Castleman's disease associated with a cerebellar chordoid meningioma and intestinal lymphangiectasia.

Authors:  Chul Jin Jeon; Mi Jin Kim; Jong Seung Lee; Ji Hyuk Lee; Doo-Sik Kong; Hyung Jin Shin; Yeon Lim Suh; Kyoung Mee Kim; Yon Ho Choe
Journal:  Childs Nerv Syst       Date:  2010-06-22       Impact factor: 1.475

Review 3.  Castleman's disease--a two compartment model of HHV8 infection.

Authors:  Klaus-Martin Schulte; Nadia Talat
Journal:  Nat Rev Clin Oncol       Date:  2010-07-06       Impact factor: 66.675

4.  Castleman's disease in the pelvic retroperitoneum: A case report and review of the Japanese literature.

Authors:  Atsushi Sato
Journal:  Int J Surg Case Rep       Date:  2012-09-26

5.  Increased interleukin-6 (IL-6) production in a young child with clinical and pathologic features of multicentric Castleman's disease.

Authors:  M C Kinney; D S Hummell; P M Villiger; A Hourigan; L Rollins-Smith; A D Glick; A R Lawton
Journal:  J Clin Immunol       Date:  1994-11       Impact factor: 8.317

6.  Laparoscopic approach to the management of intraabdominal unicentric Castleman's disease.

Authors:  M D Williams; F A Eissien; J R Salameh; G Ailawadi; J F Sweeney
Journal:  Surg Endosc       Date:  2003-06-19       Impact factor: 4.584

7.  Unexpected uptake of technetium 99m hexakis-2-methoxy-isobutylisonitrile in giant lymph node hyperplasia of the mediastinum (Castleman's disease).

Authors:  C Aktolun; H Bayhan; B Celasun; M K Kir
Journal:  Eur J Nucl Med       Date:  1991

Review 8.  Multicentric Castleman's disease in two cases.

Authors:  Rajni Sharma; Rachna Seth; V Thavaraj; A Bagga; S K Kabra; A K Karak; S Atri
Journal:  Indian J Pediatr       Date:  2007-12       Impact factor: 5.319

9.  Castleman disease.

Authors:  Ibrahiem Saeed-Abdul-Rahman; Ali M Al-Amri
Journal:  Korean J Hematol       Date:  2012-09-25

10.  International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.

Authors:  Frits van Rhee; Peter Voorhees; Angela Dispenzieri; Alexander Fosså; Gordan Srkalovic; Makoto Ide; Nikhil Munshi; Stephen Schey; Matthew Streetly; Sheila K Pierson; Helen L Partridge; Sudipto Mukherjee; Dustin Shilling; Katie Stone; Amy Greenway; Jason Ruth; Mary Jo Lechowicz; Shanmuganathan Chandrakasan; Raj Jayanthan; Elaine S Jaffe; Heather Leitch; Naveen Pemmaraju; Amy Chadburn; Megan S Lim; Kojo S Elenitoba-Johnson; Vera Krymskaya; Aaron Goodman; Christian Hoffmann; Pier Luigi Zinzani; Simone Ferrero; Louis Terriou; Yasuharu Sato; David Simpson; Raymond Wong; Jean-Francois Rossi; Sunita Nasta; Kazuyuki Yoshizaki; Razelle Kurzrock; Thomas S Uldrick; Corey Casper; Eric Oksenhendler; David C Fajgenbaum
Journal:  Blood       Date:  2018-09-04       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.